InvestorsHub Logo
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: MD-420 post# 16888

Friday, 05/05/2017 9:46:59 PM

Friday, May 05, 2017 9:46:59 PM

Post# of 37500
Thx_MD_My_All_Focus_is_on_OMHE_because_PPS_is_very_low_&_expected_profit_margin_is_HIGH

OMHE is doing all in a planned manner:

1) Purchased VTCQ shell, for a $6Mil existing rev company
2) Changed to OMHE
3) Completed 17Q1, Q2 10-Qs
4) Announced CEO Name
5) Reviewed/Released 17Q1, Q2 10-Qs
6) Announced OTCQB uplist plan
7) In Feb 2017, CEO released his comprehensive vision
8) Released 17Q3 10-Q timely (within allowed extended period)
9) R&D work and uplist is in progress in the background
10) Secured $1Mil financing
11) Developed/Announced Cannabis/Biotech R&D Lab launch

Expected upcoming BIG developments/announcements include:

12) Progress on OTCQB uplist
13) 174Q record revenue numbers
14) 2017 10-K Release
15) Approval of OTCQB uplist application
16) New Business acquisitions
17) News about Cannabis product development in OMHE R&D Lab
18) News about Anti-aging product development in OMHE R&D Lab
19) Marketing/Sales/Rev generation from their own developed products.
20) Huge investments because R&D work attract big investors

All of above is unfolding in front of our eyes but some are in denial mode!!!

I have a long list on mind, will share later. Next week is HUGE!